Search

Your search keyword '"Mijares, Verónica"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Mijares, Verónica" Remove constraint Author: "Mijares, Verónica"
42 results on '"Mijares, Verónica"'

Search Results

1. Influence of MUC5B gene on antisynthetase syndrome

4. Brief Report: Association of HLA–DRB1*01 With IgA Vasculitis (Henoch-Schönlein)

7. Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis

8. Role of vascular endotelial growth factor polymorphisms in interstitial lung disease

10. GENETIC AND FUNCTIONAL STUDY OF OMENTIN REGARDING CARDIOVASCULAR RISK IN AXIAL GENETIC AND FUNCTIONAL STUDY OF OMENTIN REGARDING CARDIOVASCULAR RISK IN AXIAL SPONDYLOARTHRITIS

11. A Genome-Wide Association Study Identifies rs116199914 As an Intergenic Variant Associated with Carotid Intima-Media Thickness in Spanish Patients with Rheumatoid Arthritis

12. OP0304 GENETIC AND FUNCTIONAL STUDY OF OMENTIN REGARDING CARDIOVASCULAR RISK IN AXIAL SPONDYLOARTHRITIS

13. FRI0006 PROTECTIVE ROLE OF THE PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) RS2495477 POLYMORPHISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SUBCLINICAL ATHEROSCLEROSIS

14. Identification of a 3′‐Untranslated Genetic Variant of RARB Associated With Carotid Intima‐Media Thickness in Rheumatoid Arthritis: A Genome‐Wide Association Study

15. P0443 Significant sE-Selectin Levels Reduction After 6 Months of Anti-TNF-α Therapy in Non-Diabetic Patients with Moderate-to-Severe Psoriasis

16. El tratamiento con Anti-Tnf en pacientes con psoriasis moderada-grave reduce de forma significativa la E-Selectina

18. Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis

19. Systemic, non Cutaneous Repercussions, of Anti-TNF Therapy in Moderate to Severe Psoriatic Patients Without Cardiovascular Risk Factors a Prospective Study of 29 Patients

20. A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis

21. Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis

22. Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis

23. Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis

25. Additional file 1: Table S1. of Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis)

26. Additional file 2: Table S2. of Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis)

27. Additional file 3: Table S3. of Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis)

29. Sclerostin serum levels in patients with systemic autoimmune diseases

30. Association of Trabecular Bone Score with Inflammation and Adiposity in Patients with Psoriasis: Effect of Adalimumab Therapy

31. Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients

32. Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis)

33. Association of HLA-B*41:02 with Henoch-Schönlein Purpura (IgA Vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status

37. Role of PTPN22and CSKgene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis)

38. Association of the Aromatase Gene Alleles With BMD: Epidemiological and Functional Evidence.

39. Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis.

40. Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients.

41. Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Schönlein purpura.

42. HLA-DRB1 association with Henoch-Schonlein purpura.

Catalog

Books, media, physical & digital resources